Aqvida is a pharmaceutical company that specializes in the development, registration, and marketing of generic drugs. The company is committed to providing high-quality, affordable medication options to patients and healthcare providers.

Aqvida

AqVida is a pharmaceutical company based in Northern Germany specialized in development, registration, manufacturing and distribution of oncology products.
Our portfolio includes the most important generics to treat most common forms of cancer.

AqVida has established itself as a major player in the field of generic oncology medicines as well as a reliable partner for oncologists and pharmacies.

For more information about AqVida, please visit us at https://www.aqvida.de/en-gb/ 

Review our social media community guideline at https://www.aqvida.de/en-gb/socialmediacommunityguideline 

Imprint 
https://www.aqvida.de/en-gb/impressum

Privacy Policy 
https://www.aqvida.de/en-gb/datenschutz

Metric
Company Name	Aqvida
Symbol
MSH ID	DE:AQVIDA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	DE
Stage
Employee Count	54
Website	aqvida.de
LinkedIn	aqvida-gmbh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

DE:AQVIDA

Aqvida

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue